A novel site-directed affinity reagent for cross-linking human hemoglobin: Bis[2-(4-phosphonooxyphenoxy)carbonylethyl]phosphinic acid

被引:4
作者
Roach, TA
Macdonald, VW
Hosmane, RS
机构
[1] Univ Maryland Baltimore Cty, Lab Drug Design & Synth, Dept Chem & Biochem, Baltimore, MD 21250 USA
[2] Walter Reed Army Med Ctr, Dept Blood Res, Washington, DC 20307 USA
关键词
D O I
10.1021/jm030645k
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Bis[2-(4-phosphonooxyphenoxy)carbonylethyl]phosphinc acid (BPPCEP) was prepared and evaluated as a site-directed affinity reagent for cross-linking human hemoglobin. It was synthesized in four steps starting from 4-benzyloxyphenol and was converted to its pentasodium salt so as to afford efficient cross-linking in an aqueous medium. The reagent was found to specifically cross-link human hemoglobin A(0) in the beta-cleft chains under oxygenated reaction conditions at neutral pH. The amino acid residues involved in the cross-linking were determined by mass spectral analyses of tryptic digest fragments of cross-linked hemoglobin, employing a MALDI-TOF mass spectrometer. The MS analyses suggested that the most likely amino acids involved in the cross-links are Val-1 or Lys-82 present on one of the beta subunits and Lys-82 or Lys- 144 on the other. Molecular modeling studies performed on the reagent-HbA(0) complex corroborated the conclusions reached by MALDI-MS analyses. The oxygen equilibrium measurements of the three major BPPCEP-cross-linked Hb products, isolated and purified by preparative cation exchange chromatography, exhibited oxygen affinity (P-50) values of 14.5, 12.1, and 15.5 Torr as compared with the P50 of 13.1 Torr for cell-free hemoglobin. The oxygen-binding cooperativity of the modified products, as determined by the Hill coefficient generated from the Hill plots of the respective P-50 values, coupled with the absence of sigmoidal shape of the O-2 equilibrium curves, was considerably lower than that of the native hemoglobin.
引用
收藏
页码:5847 / 5859
页数:13
相关论文
共 47 条
[31]   Bis[2-(4-carboxyphenoxy)carbonylethyl]phosphinic acid (BCCEP): A new reagent for hemoglobin modification [J].
Peri, SP ;
Bhadti, VS ;
Hosmane, RS .
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY, 1997, 25 (06) :511-520
[32]  
RUDOLPH AS, 1998, FRONTIERS TISSUE ENG
[33]  
SILVA MM, 1992, J BIOL CHEM, V267, P17248
[34]   HBXL99-ALPHA - A HEMOGLOBIN DERIVATIVE THAT IS CROSS-LINKED BETWEEN THE ALPHA-SUBUNITS IS USEFUL AS A BLOOD SUBSTITUTE [J].
SNYDER, SR ;
WELTY, EV ;
WALDER, RY ;
WILLIAMS, LA ;
WALDER, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (20) :7280-7284
[35]   Artificial blood [J].
Squires, JE .
SCIENCE, 2002, 295 (5557) :1002-+
[36]   Not blood simple [J].
Stokstad, E .
SCIENCE, 2002, 295 (5557) :1003-1003
[37]   Targeted O2 delivery by low-P50 hemoglobin:: a new basis for O2 therapeutics [J].
Tsai, AG ;
Vandegriff, KD ;
Intaglietta, M ;
Winslow, RM .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 285 (04) :H1411-H1419
[38]   SITE-SPECIFIC MODIFICATION OF HEMOGLOBIN BY METHYL ACETYL PHOSPHATE [J].
UENO, H ;
POSPISCHIL, MA ;
MANNING, JM ;
KLUGER, R .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1986, 244 (02) :795-800
[39]  
VANDEGRAAF KM, 1992, CONCEPTS HUMAN ANATO
[40]  
VANDEGRIFF KD, 1995, BLOOD SUBSTITUTES, P105